Exact Mass: 533.3022
Exact Mass Matches: 533.3022
Found 500 metabolites which its exact mass value is equals to given mass value 533.3022
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ergovaline
(4,6-Dimethylpyrimidin-5-yl)-[4-[4-[2-[2-methoxy-4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone
Vicriviroc
Pralsetinib
Ergovaline
D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents CONFIDENCE Claviceps purpurea sclerotia
12-O-[(2R)-N,N-dimethyl-3-methylbutanoyl]phorbol 13-acetate
Cys Ile Ile Trp
Cys Ile Leu Trp
Cys Ile Trp Ile
Cys Ile Trp Leu
Cys Lys Lys Arg
Cys Lys Gln Arg
Cys Lys Arg Lys
Cys Lys Arg Gln
Cys Leu Ile Trp
Cys Leu Leu Trp
Cys Leu Trp Ile
Cys Leu Trp Leu
Cys Gln Lys Arg
Cys Gln Arg Lys
Cys Arg Lys Lys
Cys Arg Lys Gln
Cys Arg Gln Lys
Cys Trp Ile Ile
Cys Trp Ile Leu
Cys Trp Leu Ile
Cys Trp Leu Leu
Asp Phe Pro Arg
Asp Phe Arg Pro
Asp Ile Met Arg
Asp Ile Arg Met
Asp Leu Met Arg
Asp Leu Arg Met
Asp Met Ile Arg
Asp Met Leu Arg
Asp Met Arg Ile
Asp Met Arg Leu
Asp Pro Phe Arg
Asp Pro Arg Phe
Asp Arg Phe Pro
Asp Arg Ile Met
Asp Arg Leu Met
Asp Arg Met Ile
Asp Arg Met Leu
Asp Arg Pro Phe
Glu Met Arg Val
Glu Met Val Arg
Glu Arg Met Val
Glu Arg Val Met
Glu Val Met Arg
Glu Val Arg Met
Phe Asp Pro Arg
Phe Asp Arg Pro
Phe Ile Arg Val
Phe Ile Val Arg
Phe Leu Arg Val
Phe Leu Val Arg
Phe Pro Asp Arg
Phe Pro Arg Asp
Phe Arg Asp Pro
Phe Arg Ile Val
Phe Arg Leu Val
Phe Arg Pro Asp
Phe Arg Val Ile
Phe Arg Val Leu
Phe Val Ile Arg
Phe Val Leu Arg
Phe Val Arg Ile
Phe Val Arg Leu
His His Ile Lys
His His Ile Gln
His His Lys Ile
His His Lys Leu
His His Leu Lys
His His Leu Gln
His His Gln Ile
His His Gln Leu
His Ile His Lys
His Ile His Gln
His Ile Lys His
His Ile Gln His
His Lys His Ile
His Lys His Leu
His Lys Ile His
His Lys Leu His
His Lys Ser Tyr
His Lys Tyr Ser
His Leu His Lys
His Leu His Gln
His Leu Lys His
His Leu Gln His
His Gln His Ile
His Gln His Leu
His Gln Ile His
His Gln Leu His
His Ser Lys Tyr
His Ser Tyr Lys
His Tyr Lys Ser
His Tyr Ser Lys
Ile Cys Ile Trp
Ile Cys Leu Trp
Ile Cys Trp Ile
Ile Cys Trp Leu
Ile Asp Met Arg
Ile Asp Arg Met
Ile Phe Arg Val
Ile Phe Val Arg
Ile His His Lys
Ile His His Gln
Ile His Lys His
Ile His Gln His
Ile Ile Cys Trp
Ile Ile Trp Cys
Ile Lys His His
Ile Leu Cys Trp
Ile Leu Trp Cys
Ile Met Asp Arg
Ile Met Arg Asp
Ile Gln His His
Ile Arg Asp Met
Ile Arg Phe Val
Ile Arg Met Asp
Ile Arg Val Phe
Ile Val Phe Arg
Ile Val Arg Phe
Ile Trp Cys Ile
Ile Trp Cys Leu
Ile Trp Ile Cys
Ile Trp Leu Cys
Lys Cys Lys Arg
Lys Cys Gln Arg
Lys Cys Arg Lys
Lys Cys Arg Gln
Lys His His Ile
Lys His His Leu
Lys His Ile His
Lys His Leu His
Lys His Ser Tyr
Lys His Tyr Ser
Lys Ile His His
Lys Lys Cys Arg
Lys Lys Lys Met
Lys Lys Met Lys
Lys Lys Met Gln
Lys Lys Gln Met
Lys Lys Arg Cys
Lys Leu His His
Lys Met Lys Lys
Lys Met Lys Gln
Lys Met Gln Lys
Lys Met Gln Gln
Lys Asn Ser Trp
Lys Asn Trp Ser
Lys Gln Cys Arg
Lys Gln Lys Met
Lys Gln Met Lys
Lys Gln Met Gln
Lys Gln Gln Met
Lys Gln Arg Cys
Lys Arg Cys Lys
Lys Arg Cys Gln
Lys Arg Lys Cys
Lys Arg Gln Cys
Lys Ser His Tyr
Lys Ser Asn Trp
Lys Ser Trp Asn
Lys Ser Tyr His
Lys Trp Asn Ser
Lys Trp Ser Asn
Lys Tyr His Ser
Lys Tyr Ser His
Leu Cys Ile Trp
Leu Cys Leu Trp
Leu Cys Trp Ile
Leu Cys Trp Leu
Leu Asp Met Arg
Leu Asp Arg Met
Leu Phe Arg Val
Leu Phe Val Arg
Leu His His Lys
Leu His His Gln
Leu His Lys His
Leu His Gln His
Leu Ile Cys Trp
Leu Ile Trp Cys
Leu Lys His His
Leu Leu Cys Trp
Leu Leu Trp Cys
Leu Met Asp Arg
Leu Met Arg Asp
Leu Gln His His
Leu Arg Asp Met
Leu Arg Phe Val
Leu Arg Met Asp
Leu Arg Val Phe
Leu Val Phe Arg
Leu Val Arg Phe
Leu Trp Cys Ile
Leu Trp Cys Leu
Leu Trp Ile Cys
Leu Trp Leu Cys
Met Asp Ile Arg
Met Asp Leu Arg
Met Asp Arg Ile
Met Asp Arg Leu
Met Glu Arg Val
Met Glu Val Arg
Met Ile Asp Arg
Met Ile Arg Asp
Met Lys Lys Lys
Met Lys Lys Gln
Met Lys Gln Lys
Met Lys Gln Gln
Met Leu Asp Arg
Met Leu Arg Asp
Met Gln Lys Lys
Met Gln Lys Gln
Met Gln Gln Lys
Met Arg Asp Ile
Met Arg Asp Leu
Met Arg Glu Val
Met Arg Ile Asp
Met Arg Leu Asp
Met Arg Val Glu
Met Val Glu Arg
Met Val Arg Glu
Met Val Val Trp
Met Val Trp Val
Met Trp Val Val
Asn Lys Ser Trp
Asn Lys Trp Ser
Asn Ser Lys Trp
Asn Ser Trp Lys
Asn Trp Lys Ser
Asn Trp Ser Lys
Pro Asp Phe Arg
Pro Asp Arg Phe
Pro Phe Asp Arg
Pro Phe Arg Asp
Pro Arg Asp Phe
Pro Arg Phe Asp
Pro Arg Val Tyr
Pro Arg Tyr Val
Pro Val Arg Tyr
Pro Val Tyr Arg
Pro Tyr Arg Val
Pro Tyr Val Arg
Gln Cys Lys Arg
Gln Cys Arg Lys
Gln His His Ile
Gln His His Leu
Gln His Ile His
Gln His Leu His
Gln Ile His His
Gln Lys Cys Arg
Gln Lys Lys Met
Gln Lys Met Lys
Gln Lys Met Gln
Gln Lys Gln Met
Gln Lys Arg Cys
Gln Leu His His
Gln Met Lys Lys
Gln Met Lys Gln
Gln Met Gln Lys
Gln Gln Lys Met
Gln Gln Met Lys
Gln Arg Cys Lys
Gln Arg Lys Cys
Arg Cys Lys Lys
Arg Cys Lys Gln
Arg Cys Gln Lys
Arg Asp Phe Pro
Arg Asp Ile Met
Arg Asp Leu Met
Arg Asp Met Ile
Arg Asp Met Leu
Arg Asp Pro Phe
Arg Glu Met Val
Arg Glu Val Met
Arg Phe Asp Pro
Arg Phe Ile Val
Arg Phe Leu Val
Arg Phe Pro Asp
Arg Phe Val Ile
Arg Phe Val Leu
Arg Ile Asp Met
Arg Ile Phe Val
Arg Ile Met Asp
Arg Ile Val Phe
Arg Lys Cys Lys
Arg Lys Cys Gln
Arg Lys Lys Cys
Arg Lys Gln Cys
Arg Leu Asp Met
Arg Leu Phe Val
Arg Leu Met Asp
Arg Leu Val Phe
Arg Met Asp Ile
Arg Met Asp Leu
Arg Met Glu Val
Arg Met Ile Asp
Arg Met Leu Asp
Arg Met Val Glu
Arg Pro Asp Phe
Arg Pro Phe Asp
Arg Pro Val Tyr
Arg Pro Tyr Val
Arg Gln Cys Lys
Arg Gln Lys Cys
Arg Val Glu Met
Arg Val Phe Ile
Arg Val Phe Leu
Arg Val Ile Phe
Arg Val Leu Phe
Arg Val Met Glu
Arg Val Pro Tyr
Arg Val Tyr Pro
Arg Tyr Pro Val
Arg Tyr Val Pro
Ser His Lys Tyr
Ser His Tyr Lys
Ser Lys His Tyr
Ser Lys Asn Trp
Ser Lys Trp Asn
Ser Lys Tyr His
Ser Asn Lys Trp
Ser Asn Trp Lys
Ser Trp Lys Asn
Ser Trp Asn Lys
Ser Tyr His Lys
Ser Tyr Lys His
Val Glu Met Arg
Val Glu Arg Met
Val Phe Ile Arg
Val Phe Leu Arg
Val Phe Arg Ile
Val Phe Arg Leu
Val Ile Phe Arg
Val Ile Arg Phe
Val Leu Phe Arg
Val Leu Arg Phe
Val Met Glu Arg
Val Met Arg Glu
Val Met Val Trp
Val Met Trp Val
Val Pro Arg Tyr
Val Pro Tyr Arg
Val Arg Glu Met
Val Arg Phe Ile
Val Arg Phe Leu
Val Arg Ile Phe
Val Arg Leu Phe
Val Arg Met Glu
Val Arg Pro Tyr
Val Arg Tyr Pro
Val Val Met Trp
Val Val Trp Met
Val Trp Met Val
Val Trp Val Met
Val Tyr Pro Arg
Val Tyr Arg Pro
Trp Cys Ile Ile
Trp Cys Ile Leu
Trp Cys Leu Ile
Trp Cys Leu Leu
Trp Ile Cys Ile
Trp Ile Cys Leu
Trp Ile Ile Cys
Trp Ile Leu Cys
Trp Lys Asn Ser
Trp Lys Ser Asn
Trp Leu Cys Ile
Trp Leu Cys Leu
Trp Leu Ile Cys
Trp Leu Leu Cys
Trp Met Val Val
Trp Asn Lys Ser
Trp Asn Ser Lys
Trp Ser Lys Asn
Trp Ser Asn Lys
Trp Val Met Val
Trp Val Val Met
Tyr His Lys Ser
Tyr His Ser Lys
Tyr Lys His Ser
Tyr Lys Ser His
Tyr Pro Arg Val
Tyr Pro Val Arg
Tyr Arg Pro Val
Tyr Arg Val Pro
Tyr Val Pro Arg
Tyr Val Arg Pro
ibha#24
An (omega-1)-hydroxy fatty acid ascaroside that is bhas#24 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
ibho#24
An omega-hydroxy fatty acid ascaroside that is bhos#24 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
Vicriviroc
C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist
1-(1-propylbenzimidazol-2-yl)-N,N-bis[(1-propylbenzimidazol-2-yl)methyl]methanamine
Pralsetinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
(3R)-14-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}-3-hydroxymyristic acid
(3R,13R)-13-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}-3-hydroxymyristic acid
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-2-phenylethenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
(4E,8E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]dodeca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytetradeca-4,8,12-triene-1-sulfonic acid
4-[3-acetyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[3-acetyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
phosphatidylcholine 18:2
A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 18 carbons and 2 double bonds.
PC(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(17:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(21:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePE(19:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved